Literature DB >> 34648090

The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese.

Qian Yi1, Ziyang Ren1, Guannan Bai2, Siyu Zhu1, Shuting Li1, Chunlu Li3, Hongjiang Wu4, Yimin Zhu5, Peige Song6.   

Abstract

AIMS: Atherogenic Index of Plasma (AIP) has been proposed as a novel marker of plasma atherogenicity, but its longitudinal predictive value in type 2 diabetes mellitus (T2DM) remains unclear. We aimed to assess the associations of AIP and its longitudinal transition with T2DM among middle-aged and older Chinese.
METHODS: Data were extracted from four rounds of the China Health and Retirement Longitudinal Study (2011, 2013, 2015, and 2018). AIP was calculated as log10 (triglyceride/high-density lipoprotein cholesterol). Participants were classified into high and low AIP groups at baseline, and subsequently into four transition patterns during follow-up: maintained-high, maintained-low, high-to-low, and low-to-high AIP. Multivariable Cox frailty models were applied to explore the longitudinal transition patterns of AIP on the development of T2DM.
RESULTS: A total of 8760 subjects without T2DM were selected in 2011, of which 981 developed T2DM until 2018. When compared with people with maintained-low AIP patterns, those with transition patterns of maintained-high AIP, high-to-low AIP, and low-to-high AIP were at around 1.5 times higher risk of T2DM (HRadj = 1.69, 1.32, and 1.47, respectively, all P < 0.05). However, the risk of T2DM did not decrease in the high-to-low AIP group as compared to the maintained-high AIP group.
CONCLUSIONS: Three longitudinal AIP transition patterns (maintained-high AIP, high-to-low AIP, and low-to-high AIP) were associated with the development of T2DM. Preventions are needed to combat T2DM at an early dyslipidemic stage.
© 2021. Springer-Verlag Italia S.r.l., part of Springer Nature.

Entities:  

Keywords:  Atherogenic Index of Plasma; Cohort study; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2021        PMID: 34648090     DOI: 10.1007/s00592-021-01801-y

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  3 in total

1.  [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].

Authors:  M Dobiásová; J Frohlich
Journal:  Vnitr Lek       Date:  2000-03

2.  Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.

Authors:  G Steiner; M Vranic
Journal:  Int J Obes       Date:  1982

3.  An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients.

Authors:  Suchitra Mustur Manohar; Seshadri Reddy Vaikasuvu; K Deepthi; Alok Sachan; Srinivasa Rao Pemmaraju Venkata Lakshmi Narasimha
Journal:  J Res Med Sci       Date:  2013-02       Impact factor: 1.852

  3 in total
  1 in total

1.  A Cross-Sectional Study of the Correlation Between the Atherogenic Index of Plasma and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.

Authors:  Jie Lin; Hang Li; Qin Wan
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-30       Impact factor: 3.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.